Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $857 - $1,013
-4 Reduced 0.32%
1,258 $279,000
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $9,031 - $11,008
-40 Reduced 3.07%
1,262 $305,000
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $137,418 - $174,606
-600 Reduced 31.55%
1,302 $341,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $689,990 - $778,183
-3,074 Reduced 61.78%
1,902 $429,000
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $317,226 - $353,017
1,375 Added 38.18%
4,976 $1.21 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $224,532 - $248,391
1,024 Added 39.74%
3,601 $871,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $1,789 - $2,048
-9 Reduced 0.35%
2,577 $580,000
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $34,175 - $40,040
161 Added 6.64%
2,586 $550,000
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $387,742 - $430,172
-1,660 Reduced 40.64%
2,425 $591,000
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $108,070 - $125,938
487 Added 13.54%
4,085 $1.02 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $125,500 - $149,448
580 Added 19.22%
3,598 $827,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $140,320 - $156,048
598 Added 24.71%
3,018 $729,000
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $226,888 - $278,422
1,147 Added 90.1%
2,420 $571,000
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $75,629 - $100,305
415 Added 48.37%
1,273 $258,000
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $162,342 - $208,665
858 New
858 $207,000
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $150,256 - $180,039
-863 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$166.7 - $195.41 $143,862 - $168,638
863 New
863 $0
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $267,868 - $301,946
-1,481 Closed
0 $0
Q4 2018

Jan 25, 2019

BUY
$178.4 - $208.25 $6,065 - $7,080
34 Added 2.35%
1,481 $288,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $268,114 - $302,263
1,447 New
1,447 $286,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Almanack Investment Partners, Llc. Portfolio

Follow Almanack Investment Partners, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.